A new trial date has yet to be set for Forest Laboratories Inc.’s patent infringement complaint against Mylan.
In January 2008, Forest Laboratories and Merz, the Company’s licensor for Namenda, commenced…
Pfizer Inc. pursues a patent infringement action against Matrix Laboratories Limited, Mylan Inc., and another subsidiary of Mylan.
In May 2009, Matrix, a subsidiary of Mylan, notified the Company that it…
Abbott pursues patent infringement actions against Matrix Laboratories, Inc., Matrix Laboratories, Ltd., and Mylan, Inc.
Abbott is seeking to enforce its patents rights relating to ritonavir/lopinavir tablets, a drug the Company…
The Court of Appeals for the Federal Circuit, on July 21, 2008, affirmed the decision upholding the enforceability of the patent on ACIPHEX(R), according to Johnson & Johnson’s Form 10-Q…